Xerimis announces the debut of its purpose-built, 13,000-square foot United Kingdom facility

Xerimis announces the debut of its purpose-built, 13,000-square foot United Kingdom facility – the second location for the privately held, New Jersey-headquartered customized clinical packaging provider.

blue-plus Continue Reading
EventNovember 30 – December 1, 2016

Xerimis to exhibit at Clinical Trial Supply-East Asia / Exhibit

This event runs from November 30 – December 1, 2016, in Seoul, Korea. Visit Xerimis at Booth #19.

blue-plus Continue Reading Seoul, Korea

Xerimis Increases Capabilities with Cutting-edge Technology

With over 40 years of experience, Dr. Peter Bernardo has been instrumental in initiating and accommodating tremendous changes in the pharmaceutical industry.

blue-plus Continue Reading

Xerimis Expands Controlled Substances Capabilites

Xerimis Inc. has been approved by the DEA as a registered distributor of schedule 3 through 5 controlled substances.

blue-plus Continue Reading